| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 62 | 2023 | 106 | 16.880 |
Why?
|
| Nicotine | 36 | 2026 | 144 | 12.620 |
Why?
|
| Prenatal Exposure Delayed Effects | 22 | 2026 | 93 | 9.960 |
Why?
|
| PPAR gamma | 38 | 2024 | 51 | 6.610 |
Why?
|
| Animals | 92 | 2026 | 1875 | 6.020 |
Why?
|
| Rats, Sprague-Dawley | 51 | 2026 | 282 | 5.710 |
Why?
|
| Pulmonary Alveoli | 28 | 2020 | 33 | 5.680 |
Why?
|
| Fibroblasts | 27 | 2020 | 53 | 4.910 |
Why?
|
| Electroacupuncture | 9 | 2023 | 9 | 4.900 |
Why?
|
| Pregnancy | 56 | 2026 | 599 | 4.790 |
Why?
|
| Rats | 54 | 2026 | 571 | 4.740 |
Why?
|
| Nicotinic Agonists | 10 | 2024 | 38 | 3.890 |
Why?
|
| Hyperoxia | 13 | 2023 | 18 | 3.850 |
Why?
|
| Female | 85 | 2026 | 4060 | 3.830 |
Why?
|
| Asthma | 11 | 2022 | 31 | 3.790 |
Why?
|
| Cell Differentiation | 22 | 2021 | 101 | 3.500 |
Why?
|
| Animals, Newborn | 32 | 2021 | 112 | 3.210 |
Why?
|
| Thiazolidinediones | 13 | 2016 | 39 | 3.060 |
Why?
|
| Bronchopulmonary Dysplasia | 8 | 2020 | 9 | 3.000 |
Why?
|
| Parathyroid Hormone-Related Protein | 19 | 2011 | 22 | 2.540 |
Why?
|
| Lung Injury | 6 | 2023 | 9 | 2.460 |
Why?
|
| Fetal Growth Retardation | 6 | 2020 | 42 | 2.310 |
Why?
|
| Signal Transduction | 18 | 2024 | 246 | 2.280 |
Why?
|
| Male | 46 | 2026 | 3671 | 2.010 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 4 | 2020 | 25 | 1.940 |
Why?
|
| Smoking | 8 | 2019 | 86 | 1.920 |
Why?
|
| MicroRNAs | 7 | 2026 | 54 | 1.910 |
Why?
|
| Phenotype | 14 | 2026 | 91 | 1.880 |
Why?
|
| Cells, Cultured | 21 | 2024 | 234 | 1.860 |
Why?
|
| Infant, Newborn | 35 | 2019 | 199 | 1.660 |
Why?
|
| Maternal Exposure | 7 | 2020 | 17 | 1.650 |
Why?
|
| Myocardium | 3 | 2026 | 25 | 1.640 |
Why?
|
| Epigenesis, Genetic | 5 | 2024 | 36 | 1.610 |
Why?
|
| Humans | 72 | 2020 | 6794 | 1.570 |
Why?
|
| Caloric Restriction | 5 | 2020 | 13 | 1.480 |
Why?
|
| Breath Tests | 4 | 2012 | 7 | 1.450 |
Why?
|
| Spermatozoa | 2 | 2022 | 9 | 1.430 |
Why?
|
| Fetus | 10 | 2019 | 125 | 1.420 |
Why?
|
| Adipogenesis | 3 | 2020 | 13 | 1.300 |
Why?
|
| Myofibroblasts | 4 | 2024 | 7 | 1.220 |
Why?
|
| Wnt Proteins | 5 | 2023 | 15 | 1.170 |
Why?
|
| Epithelial Cells | 8 | 2016 | 49 | 1.170 |
Why?
|
| Vitamin D Deficiency | 2 | 2021 | 24 | 1.130 |
Why?
|
| Wnt Signaling Pathway | 5 | 2023 | 13 | 1.110 |
Why?
|
| RNA, Long Noncoding | 2 | 2026 | 20 | 1.090 |
Why?
|
| Pituitary-Adrenal System | 4 | 2020 | 13 | 1.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 2020 | 18 | 1.050 |
Why?
|
| DNA Methylation | 5 | 2024 | 26 | 1.030 |
Why?
|
| Calcitriol | 4 | 2016 | 18 | 1.030 |
Why?
|
| Gestational Age | 11 | 2020 | 58 | 1.010 |
Why?
|
| Extracellular Matrix | 2 | 2020 | 22 | 1.000 |
Why?
|
| Metyrapone | 3 | 2018 | 7 | 0.980 |
Why?
|
| RNA, Messenger | 12 | 2023 | 190 | 0.980 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 3 | 2017 | 6 | 0.970 |
Why?
|
| Heart | 1 | 2026 | 25 | 0.960 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2021 | 34 | 0.940 |
Why?
|
| Infant, Premature | 11 | 2018 | 23 | 0.940 |
Why?
|
| Transforming Growth Factor beta | 5 | 2023 | 55 | 0.940 |
Why?
|
| Vitamin D | 4 | 2021 | 45 | 0.940 |
Why?
|
| Acute Lung Injury | 3 | 2023 | 4 | 0.930 |
Why?
|
| Biological Evolution | 3 | 2011 | 17 | 0.930 |
Why?
|
| beta Catenin | 6 | 2023 | 15 | 0.910 |
Why?
|
| Acupuncture Points | 4 | 2020 | 5 | 0.870 |
Why?
|
| Membrane Proteins | 10 | 2011 | 48 | 0.870 |
Why?
|
| Models, Biological | 5 | 2011 | 64 | 0.830 |
Why?
|
| Vaping | 1 | 2024 | 26 | 0.830 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 15 | 0.820 |
Why?
|
| Muscle Development | 3 | 2021 | 19 | 0.810 |
Why?
|
| Bone Marrow Cells | 2 | 2024 | 3 | 0.800 |
Why?
|
| RNA | 2 | 2022 | 25 | 0.790 |
Why?
|
| Curcumin | 2 | 2013 | 8 | 0.750 |
Why?
|
| Diaphragm | 4 | 2003 | 13 | 0.720 |
Why?
|
| Mesoderm | 6 | 2016 | 15 | 0.720 |
Why?
|
| Pulmonary Surfactants | 6 | 2021 | 9 | 0.710 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 231 | 0.700 |
Why?
|
| Acupuncture Therapy | 1 | 2021 | 4 | 0.690 |
Why?
|
| Triglycerides | 6 | 2013 | 58 | 0.680 |
Why?
|
| Up-Regulation | 8 | 2024 | 94 | 0.680 |
Why?
|
| Uterus | 2 | 2020 | 15 | 0.680 |
Why?
|
| Infant, Extremely Low Birth Weight | 2 | 2017 | 3 | 0.670 |
Why?
|
| Paracrine Communication | 5 | 2009 | 9 | 0.660 |
Why?
|
| Vitamin A | 1 | 2020 | 3 | 0.660 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 2 | 2011 | 16 | 0.660 |
Why?
|
| Respiration | 8 | 2009 | 13 | 0.650 |
Why?
|
| Sexual Maturation | 1 | 2020 | 2 | 0.650 |
Why?
|
| Heart Diseases | 1 | 2020 | 9 | 0.650 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 5 | 2016 | 5 | 0.650 |
Why?
|
| Down-Regulation | 6 | 2020 | 57 | 0.640 |
Why?
|
| Perilipin-2 | 10 | 2011 | 10 | 0.630 |
Why?
|
| Homeostasis | 7 | 2019 | 40 | 0.620 |
Why?
|
| Phylogeny | 3 | 2011 | 20 | 0.620 |
Why?
|
| Oxygen | 7 | 2011 | 44 | 0.620 |
Why?
|
| Respiratory Mechanics | 3 | 2012 | 6 | 0.610 |
Why?
|
| Cell Proliferation | 6 | 2024 | 143 | 0.610 |
Why?
|
| Lipogenesis | 2 | 2018 | 6 | 0.600 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2016 | 15 | 0.600 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 2 | 2016 | 4 | 0.590 |
Why?
|
| Cell Transdifferentiation | 4 | 2011 | 8 | 0.580 |
Why?
|
| Nutritional Status | 2 | 2020 | 64 | 0.560 |
Why?
|
| Proteins | 2 | 2012 | 41 | 0.560 |
Why?
|
| Phospholipids | 4 | 2013 | 6 | 0.560 |
Why?
|
| Evolution, Molecular | 3 | 2009 | 7 | 0.560 |
Why?
|
| Proteolipids | 1 | 2018 | 2 | 0.550 |
Why?
|
| Protein Precursors | 1 | 2018 | 15 | 0.550 |
Why?
|
| Respiratory Function Tests | 5 | 2020 | 5 | 0.550 |
Why?
|
| Lung Diseases | 3 | 2020 | 9 | 0.550 |
Why?
|
| Biomarkers | 9 | 2014 | 214 | 0.550 |
Why?
|
| Ventilator Weaning | 1 | 2017 | 3 | 0.540 |
Why?
|
| Infant, Extremely Premature | 1 | 2017 | 3 | 0.540 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2017 | 2 | 0.540 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2014 | 6 | 0.540 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 8 | 2015 | 9 | 0.540 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2013 | 6 | 0.530 |
Why?
|
| Leptin | 3 | 2009 | 21 | 0.530 |
Why?
|
| Fibronectins | 5 | 2016 | 18 | 0.520 |
Why?
|
| Surface-Active Agents | 4 | 2023 | 5 | 0.520 |
Why?
|
| Mice | 12 | 2023 | 746 | 0.500 |
Why?
|
| Vitamins | 1 | 2016 | 14 | 0.500 |
Why?
|
| Cell Respiration | 1 | 2016 | 2 | 0.480 |
Why?
|
| Actins | 7 | 2011 | 28 | 0.480 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 3 | 0.480 |
Why?
|
| Glucocorticoids | 5 | 2021 | 65 | 0.480 |
Why?
|
| Mitochondria | 1 | 2016 | 37 | 0.470 |
Why?
|
| Apoptosis | 4 | 2013 | 179 | 0.460 |
Why?
|
| Exhalation | 2 | 2012 | 3 | 0.460 |
Why?
|
| Gene Expression Regulation | 5 | 2014 | 120 | 0.440 |
Why?
|
| Cholecalciferol | 1 | 2014 | 8 | 0.440 |
Why?
|
| Trachea | 3 | 2012 | 8 | 0.430 |
Why?
|
| Hydrogen Peroxide | 2 | 2012 | 9 | 0.430 |
Why?
|
| Adipocytes | 3 | 2021 | 31 | 0.430 |
Why?
|
| Age Factors | 4 | 2020 | 193 | 0.430 |
Why?
|
| Dietary Supplements | 1 | 2014 | 44 | 0.420 |
Why?
|
| Sex Factors | 3 | 2020 | 155 | 0.410 |
Why?
|
| Steroid Synthesis Inhibitors | 1 | 2013 | 2 | 0.410 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2013 | 5 | 0.410 |
Why?
|
| Malnutrition | 1 | 2014 | 51 | 0.410 |
Why?
|
| Protective Agents | 1 | 2013 | 4 | 0.400 |
Why?
|
| Prostaglandin D2 | 4 | 2009 | 4 | 0.400 |
Why?
|
| Calcium-Binding Proteins | 4 | 2020 | 8 | 0.390 |
Why?
|
| Infant, Premature, Diseases | 4 | 2014 | 7 | 0.390 |
Why?
|
| Temperature | 1 | 2012 | 8 | 0.390 |
Why?
|
| Nitrites | 1 | 2012 | 8 | 0.390 |
Why?
|
| Fetal Organ Maturity | 3 | 2009 | 6 | 0.390 |
Why?
|
| Sex Characteristics | 4 | 2020 | 39 | 0.380 |
Why?
|
| Cell Communication | 2 | 2009 | 11 | 0.380 |
Why?
|
| Hypoglycemic Agents | 2 | 2011 | 165 | 0.380 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2021 | 155 | 0.370 |
Why?
|
| Administration, Inhalation | 3 | 2018 | 9 | 0.370 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 5 | 0.360 |
Why?
|
| High-Frequency Ventilation | 1 | 2011 | 1 | 0.360 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2011 | 1 | 0.360 |
Why?
|
| Parturition | 3 | 2021 | 5 | 0.360 |
Why?
|
| Electronic Nicotine Delivery Systems | 2 | 2024 | 58 | 0.350 |
Why?
|
| Selection, Genetic | 1 | 2011 | 3 | 0.350 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 33 | 0.350 |
Why?
|
| Vertebrates | 1 | 2011 | 6 | 0.350 |
Why?
|
| Acid-Base Imbalance | 1 | 2011 | 2 | 0.340 |
Why?
|
| Lactic Acid | 1 | 2011 | 8 | 0.340 |
Why?
|
| Receptors, Nicotinic | 4 | 2015 | 10 | 0.340 |
Why?
|
| Kidney | 5 | 2016 | 184 | 0.340 |
Why?
|
| Gene Regulatory Networks | 2 | 2009 | 8 | 0.330 |
Why?
|
| Lipopolysaccharides | 2 | 2007 | 41 | 0.320 |
Why?
|
| Premature Birth | 2 | 2021 | 8 | 0.310 |
Why?
|
| Membrane Lipids | 1 | 2009 | 4 | 0.310 |
Why?
|
| Lymphocytes | 2 | 2019 | 17 | 0.300 |
Why?
|
| Xenopus laevis | 1 | 2009 | 5 | 0.300 |
Why?
|
| Respiratory System Agents | 1 | 2009 | 1 | 0.300 |
Why?
|
| Preventive Medicine | 1 | 2009 | 5 | 0.300 |
Why?
|
| Methacholine Chloride | 3 | 2014 | 3 | 0.290 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2019 | 10 | 0.280 |
Why?
|
| Time Factors | 7 | 2016 | 321 | 0.280 |
Why?
|
| Respiration, Artificial | 4 | 2018 | 19 | 0.280 |
Why?
|
| Cerebrovascular Circulation | 3 | 2000 | 9 | 0.270 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2020 | 25 | 0.270 |
Why?
|
| Infant | 7 | 2017 | 187 | 0.270 |
Why?
|
| Philosophy | 1 | 2007 | 1 | 0.270 |
Why?
|
| Models, Animal | 3 | 2020 | 23 | 0.270 |
Why?
|
| Religion | 1 | 2007 | 16 | 0.270 |
Why?
|
| Hypoxia | 4 | 2011 | 37 | 0.260 |
Why?
|
| Cell Line | 7 | 2015 | 124 | 0.260 |
Why?
|
| Bone and Bones | 2 | 2007 | 16 | 0.260 |
Why?
|
| Trans-Activators | 1 | 2006 | 10 | 0.250 |
Why?
|
| Body Weight | 2 | 2023 | 90 | 0.250 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2026 | 2 | 0.240 |
Why?
|
| Base Sequence | 4 | 2015 | 65 | 0.240 |
Why?
|
| Cell Movement | 2 | 2024 | 38 | 0.240 |
Why?
|
| Triolein | 3 | 2016 | 3 | 0.230 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2016 | 2 | 0.230 |
Why?
|
| Fetofetal Transfusion | 2 | 1995 | 8 | 0.230 |
Why?
|
| Microfilament Proteins | 3 | 2011 | 7 | 0.230 |
Why?
|
| Sleep | 3 | 2000 | 14 | 0.220 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2020 | 21 | 0.220 |
Why?
|
| Calcium | 2 | 2016 | 117 | 0.220 |
Why?
|
| Angiotensins | 1 | 2024 | 1 | 0.220 |
Why?
|
| Carotid Body | 1 | 2024 | 1 | 0.220 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2024 | 4 | 0.220 |
Why?
|
| Epinephrine | 1 | 2004 | 9 | 0.220 |
Why?
|
| Resuscitation | 1 | 2004 | 6 | 0.220 |
Why?
|
| Genome | 1 | 2004 | 7 | 0.220 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2015 | 2 | 0.220 |
Why?
|
| Pulmonary Emphysema | 1 | 2004 | 2 | 0.210 |
Why?
|
| Portal Vein | 2 | 1994 | 2 | 0.210 |
Why?
|
| Fibroblast Growth Factor 10 | 2 | 2015 | 2 | 0.210 |
Why?
|
| Hirschsprung Disease | 2 | 2014 | 2 | 0.210 |
Why?
|
| Thrombosis | 2 | 1994 | 13 | 0.210 |
Why?
|
| Blood Pressure | 1 | 2024 | 112 | 0.210 |
Why?
|
| Glutamic Acid | 1 | 2023 | 5 | 0.210 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2023 | 3 | 0.210 |
Why?
|
| Muscle, Smooth | 3 | 2012 | 22 | 0.210 |
Why?
|
| Regeneration | 1 | 2004 | 5 | 0.210 |
Why?
|
| Hippocampus | 1 | 2023 | 19 | 0.210 |
Why?
|
| Tretinoin | 1 | 2004 | 30 | 0.210 |
Why?
|
| Prenatal Care | 2 | 2019 | 13 | 0.200 |
Why?
|
| Choline | 2 | 2016 | 7 | 0.200 |
Why?
|
| Organogenesis | 1 | 2003 | 7 | 0.200 |
Why?
|
| Blotting, Western | 3 | 2013 | 110 | 0.200 |
Why?
|
| Prenatal Diagnosis | 1 | 2003 | 11 | 0.200 |
Why?
|
| Phosphatidylcholines | 3 | 2011 | 6 | 0.200 |
Why?
|
| Hypertension | 1 | 2024 | 147 | 0.200 |
Why?
|
| Elastin | 2 | 2013 | 4 | 0.190 |
Why?
|
| Pregnancy in Diabetics | 1 | 2002 | 8 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 11 | 0.190 |
Why?
|
| Diabetes, Gestational | 1 | 2002 | 14 | 0.190 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2012 | 34 | 0.180 |
Why?
|
| Positive-Pressure Respiration | 1 | 2001 | 2 | 0.180 |
Why?
|
| Receptors, Calcitriol | 2 | 2016 | 16 | 0.180 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 98 | 0.170 |
Why?
|
| Sudden Infant Death | 2 | 2000 | 3 | 0.170 |
Why?
|
| Treatment Outcome | 3 | 2018 | 500 | 0.170 |
Why?
|
| Antioxidants | 1 | 2001 | 37 | 0.170 |
Why?
|
| Aerosols | 1 | 2020 | 15 | 0.170 |
Why?
|
| Adiponectin | 1 | 2020 | 6 | 0.170 |
Why?
|
| Adipose Tissue, White | 1 | 2020 | 9 | 0.170 |
Why?
|
| Collagen Type III | 1 | 2020 | 5 | 0.170 |
Why?
|
| Collagen Type I | 1 | 2020 | 18 | 0.160 |
Why?
|
| Acyltransferases | 1 | 2020 | 2 | 0.160 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 4 | 0.160 |
Why?
|
| Testis | 1 | 2020 | 6 | 0.160 |
Why?
|
| Lysosomes | 1 | 2020 | 14 | 0.160 |
Why?
|
| Gene Expression | 3 | 2006 | 77 | 0.160 |
Why?
|
| Fibrosis | 1 | 2020 | 53 | 0.160 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2011 | 4 | 0.160 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2020 | 2 | 0.160 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2020 | 25 | 0.160 |
Why?
|
| Corticosterone | 1 | 2020 | 24 | 0.160 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 1999 | 7 | 0.160 |
Why?
|
| Butyric Acid | 1 | 2019 | 2 | 0.160 |
Why?
|
| Logistic Models | 4 | 2019 | 165 | 0.160 |
Why?
|
| Dietary Fiber | 1 | 2019 | 9 | 0.150 |
Why?
|
| Neutrophils | 1 | 2019 | 14 | 0.150 |
Why?
|
| Protein Transport | 2 | 2011 | 23 | 0.150 |
Why?
|
| Risk Factors | 2 | 2018 | 767 | 0.150 |
Why?
|
| Fetal Development | 1 | 2019 | 28 | 0.150 |
Why?
|
| Neonatologists | 1 | 2019 | 1 | 0.150 |
Why?
|
| Stress, Mechanical | 3 | 2004 | 9 | 0.150 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 26 | 0.150 |
Why?
|
| Fetal Diseases | 1 | 2019 | 10 | 0.150 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2019 | 1 | 0.150 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 59 | 0.150 |
Why?
|
| Neoplasms | 1 | 2020 | 92 | 0.150 |
Why?
|
| Osteogenesis | 1 | 2018 | 5 | 0.150 |
Why?
|
| Blood Flow Velocity | 2 | 1996 | 11 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 8 | 0.140 |
Why?
|
| Enzyme Activation | 2 | 2020 | 39 | 0.140 |
Why?
|
| Biomimetic Materials | 1 | 2018 | 1 | 0.140 |
Why?
|
| Algorithms | 3 | 2009 | 83 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 90 | 0.140 |
Why?
|
| Oxygen Consumption | 2 | 2000 | 13 | 0.140 |
Why?
|
| Pressure | 1 | 2017 | 7 | 0.140 |
Why?
|
| Prognosis | 2 | 2018 | 220 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 63 | 0.140 |
Why?
|
| Adipose Tissue | 3 | 2019 | 69 | 0.130 |
Why?
|
| Spermatogenesis | 1 | 2017 | 1 | 0.130 |
Why?
|
| Betaine | 1 | 2017 | 6 | 0.130 |
Why?
|
| Metabolomics | 1 | 2017 | 4 | 0.130 |
Why?
|
| Alkaline Phosphatase | 2 | 2014 | 33 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2020 | 24 | 0.130 |
Why?
|
| Liver | 2 | 2009 | 157 | 0.130 |
Why?
|
| Adult | 5 | 2006 | 2113 | 0.130 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2016 | 1 | 0.130 |
Why?
|
| Indomethacin | 1 | 2016 | 4 | 0.130 |
Why?
|
| Ibuprofen | 1 | 2016 | 4 | 0.130 |
Why?
|
| Sleep Stages | 2 | 1996 | 5 | 0.130 |
Why?
|
| California | 1 | 2017 | 230 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2016 | 1 | 0.130 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2016 | 1 | 0.130 |
Why?
|
| Endothelium | 1 | 2016 | 4 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 5 | 0.130 |
Why?
|
| Receptors, Leptin | 1 | 2016 | 5 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2017 | 331 | 0.120 |
Why?
|
| Spinal Cord Injuries | 2 | 1993 | 8 | 0.120 |
Why?
|
| Birth Injuries | 2 | 1993 | 6 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 30 | 0.120 |
Why?
|
| Cadherins | 1 | 2016 | 4 | 0.120 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 14 | 0.120 |
Why?
|
| beta-Endorphin | 1 | 2016 | 15 | 0.120 |
Why?
|
| Insulin Resistance | 2 | 2019 | 74 | 0.120 |
Why?
|
| Periodicity | 1 | 1996 | 8 | 0.120 |
Why?
|
| Hemangioendothelioma | 1 | 1995 | 1 | 0.120 |
Why?
|
| Chromatin | 1 | 2015 | 3 | 0.120 |
Why?
|
| Triplets | 1 | 1995 | 2 | 0.120 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1995 | 5 | 0.120 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 40 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 279 | 0.110 |
Why?
|
| Azacitidine | 1 | 2015 | 2 | 0.110 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2015 | 3 | 0.110 |
Why?
|
| Muscle Contraction | 1 | 2015 | 13 | 0.110 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2015 | 3 | 0.110 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 70 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 1995 | 63 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 45 | 0.110 |
Why?
|
| Placenta | 1 | 1995 | 58 | 0.110 |
Why?
|
| Nitrosamines | 2 | 2011 | 6 | 0.110 |
Why?
|
| Lung Volume Measurements | 2 | 2007 | 3 | 0.110 |
Why?
|
| Cytoprotection | 1 | 2014 | 5 | 0.110 |
Why?
|
| Streptokinase | 1 | 1994 | 2 | 0.110 |
Why?
|
| DNA Primers | 2 | 2012 | 23 | 0.110 |
Why?
|
| Thrombolytic Therapy | 1 | 1994 | 2 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 44 | 0.110 |
Why?
|
| Umbilical Veins | 1 | 1994 | 3 | 0.110 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2014 | 2 | 0.110 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2014 | 2 | 0.110 |
Why?
|
| Troponin T | 1 | 2014 | 1 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 51 | 0.100 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2014 | 3 | 0.100 |
Why?
|
| Catheterization, Peripheral | 1 | 1994 | 11 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 13 | 0.100 |
Why?
|
| Airway Resistance | 2 | 2012 | 2 | 0.100 |
Why?
|
| Fluorocarbons | 1 | 2013 | 1 | 0.100 |
Why?
|
| Alkanesulfonic Acids | 1 | 2013 | 1 | 0.100 |
Why?
|
| Environmental Pollutants | 1 | 2013 | 4 | 0.100 |
Why?
|
| Rectum | 1 | 2013 | 8 | 0.100 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 4 | 0.100 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2013 | 3 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 11 | 0.100 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 5 | 0.100 |
Why?
|
| Colon | 1 | 2013 | 20 | 0.100 |
Why?
|
| Weight Gain | 1 | 2013 | 28 | 0.100 |
Why?
|
| Ultrasonography | 4 | 2014 | 38 | 0.100 |
Why?
|
| In Vitro Techniques | 2 | 2004 | 72 | 0.100 |
Why?
|
| Cell Division | 2 | 2003 | 40 | 0.100 |
Why?
|
| DNA Damage | 1 | 2013 | 20 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2014 | 108 | 0.100 |
Why?
|
| Central Nervous System | 2 | 2007 | 8 | 0.100 |
Why?
|
| Lung Compliance | 1 | 2012 | 1 | 0.100 |
Why?
|
| Sheep | 2 | 2011 | 132 | 0.100 |
Why?
|
| Embryonic Development | 1 | 2012 | 2 | 0.090 |
Why?
|
| Nasal Mucosa | 1 | 2012 | 1 | 0.090 |
Why?
|
| Body Fluids | 1 | 2012 | 8 | 0.090 |
Why?
|
| Candidiasis | 1 | 1992 | 1 | 0.090 |
Why?
|
| Autophagy | 2 | 2023 | 29 | 0.090 |
Why?
|
| Clinical Chemistry Tests | 1 | 2011 | 1 | 0.090 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2011 | 20 | 0.090 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 40 | 0.090 |
Why?
|
| Cytoplasm | 1 | 2011 | 7 | 0.090 |
Why?
|
| Genes, Regulator | 1 | 2011 | 3 | 0.090 |
Why?
|
| Collagen Type IV | 1 | 2011 | 4 | 0.090 |
Why?
|
| Environmental Exposure | 1 | 2011 | 12 | 0.090 |
Why?
|
| Air Pollutants | 1 | 2011 | 6 | 0.090 |
Why?
|
| Bungarotoxins | 1 | 2011 | 1 | 0.090 |
Why?
|
| Aldehydes | 1 | 2011 | 8 | 0.090 |
Why?
|
| Mecamylamine | 1 | 2011 | 8 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 24 | 0.090 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2010 | 7 | 0.080 |
Why?
|
| Naphthalenes | 1 | 2010 | 5 | 0.080 |
Why?
|
| Glucose | 2 | 2019 | 50 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 2010 | 31 | 0.080 |
Why?
|
| Insulin | 1 | 2011 | 146 | 0.080 |
Why?
|
| Peptides | 1 | 2010 | 19 | 0.080 |
Why?
|
| Blood Gas Analysis | 2 | 2009 | 12 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2011 | 167 | 0.080 |
Why?
|
| Muscles | 2 | 2003 | 19 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 1992 | 121 | 0.080 |
Why?
|
| Stereoisomerism | 1 | 2009 | 2 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 258 | 0.080 |
Why?
|
| Systems Biology | 1 | 2009 | 1 | 0.080 |
Why?
|
| Immunity, Innate | 2 | 2019 | 20 | 0.080 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2009 | 1 | 0.080 |
Why?
|
| Lac Operon | 1 | 2009 | 3 | 0.080 |
Why?
|
| Parathyroid Hormone | 1 | 2009 | 44 | 0.070 |
Why?
|
| Basement Membrane | 1 | 2009 | 11 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 10 | 0.070 |
Why?
|
| Locomotion | 1 | 2009 | 6 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 14 | 0.070 |
Why?
|
| Carbon Dioxide | 2 | 2000 | 17 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 50 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2009 | 15 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2019 | 150 | 0.070 |
Why?
|
| Cardiovascular System | 2 | 2007 | 21 | 0.070 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2008 | 4 | 0.070 |
Why?
|
| Cell Survival | 2 | 2013 | 33 | 0.070 |
Why?
|
| History, 19th Century | 1 | 2007 | 4 | 0.070 |
Why?
|
| Fishes | 1 | 2007 | 9 | 0.070 |
Why?
|
| Bucladesine | 1 | 2007 | 4 | 0.070 |
Why?
|
| Nicotinic Antagonists | 1 | 2007 | 4 | 0.070 |
Why?
|
| Immunoassay | 1 | 2007 | 8 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 9 | 0.070 |
Why?
|
| PPAR alpha | 1 | 2007 | 9 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2007 | 38 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2007 | 45 | 0.060 |
Why?
|
| Meconium | 1 | 2007 | 8 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2007 | 38 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2007 | 56 | 0.060 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2007 | 20 | 0.060 |
Why?
|
| Azo Compounds | 1 | 2006 | 1 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2006 | 2 | 0.060 |
Why?
|
| Bumetanide | 1 | 2006 | 3 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2006 | 3 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2006 | 6 | 0.060 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2006 | 2 | 0.060 |
Why?
|
| Suction | 1 | 2006 | 2 | 0.060 |
Why?
|
| Inclusion Bodies | 1 | 2006 | 20 | 0.060 |
Why?
|
| Anilides | 1 | 2006 | 5 | 0.060 |
Why?
|
| Pancreas | 1 | 2007 | 144 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2005 | 8 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2016 | 101 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2005 | 30 | 0.060 |
Why?
|
| Mouth Breathing | 2 | 1995 | 2 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 156 | 0.060 |
Why?
|
| Tritium | 1 | 2004 | 4 | 0.060 |
Why?
|
| Catheterization | 1 | 2004 | 7 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2004 | 11 | 0.050 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2004 | 1 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 14 | 0.050 |
Why?
|
| United States | 2 | 2019 | 1019 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2023 | 1 | 0.050 |
Why?
|
| Poly I-C | 1 | 2023 | 1 | 0.050 |
Why?
|
| Body Height | 1 | 2003 | 5 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2002 | 268 | 0.050 |
Why?
|
| Papio | 1 | 2003 | 1 | 0.050 |
Why?
|
| Dinoprost | 1 | 2003 | 1 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 56 | 0.050 |
Why?
|
| Macrophages | 1 | 2023 | 40 | 0.050 |
Why?
|
| Endoderm | 1 | 2003 | 1 | 0.050 |
Why?
|
| Peptide Hormones | 1 | 2003 | 5 | 0.050 |
Why?
|
| Cell Hypoxia | 1 | 2003 | 7 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2003 | 45 | 0.050 |
Why?
|
| Infant Mortality | 1 | 2002 | 7 | 0.050 |
Why?
|
| Receptors, Parathyroid Hormone | 1 | 2002 | 1 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2002 | 18 | 0.050 |
Why?
|
| Random Allocation | 2 | 2019 | 27 | 0.050 |
Why?
|
| Anthropometry | 1 | 2001 | 16 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2001 | 63 | 0.040 |
Why?
|
| Culture Media | 1 | 2001 | 3 | 0.040 |
Why?
|
| Dihydrotestosterone | 1 | 2001 | 5 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2001 | 11 | 0.040 |
Why?
|
| Glutathione | 1 | 2001 | 14 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2002 | 285 | 0.040 |
Why?
|
| Rabbits | 1 | 2021 | 48 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2001 | 30 | 0.040 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2000 | 2 | 0.040 |
Why?
|
| Biological Clocks | 1 | 2000 | 5 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 79 | 0.040 |
Why?
|
| Supine Position | 1 | 2000 | 1 | 0.040 |
Why?
|
| Prone Position | 1 | 2000 | 1 | 0.040 |
Why?
|
| Endosomes | 1 | 2020 | 2 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 5 | 0.040 |
Why?
|
| Blood Viscosity | 1 | 2000 | 6 | 0.040 |
Why?
|
| Intestines | 1 | 2000 | 7 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2000 | 82 | 0.040 |
Why?
|
| Radiography, Abdominal | 1 | 1999 | 2 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 1999 | 8 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 1999 | 13 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 46 | 0.040 |
Why?
|
| Rubella | 1 | 2019 | 1 | 0.040 |
Why?
|
| Toxoplasmosis, Congenital | 1 | 2019 | 1 | 0.040 |
Why?
|
| Herpes Simplex | 1 | 2019 | 3 | 0.040 |
Why?
|
| Syphilis | 1 | 2019 | 5 | 0.040 |
Why?
|
| Apnea | 2 | 1996 | 3 | 0.040 |
Why?
|
| Brain | 2 | 2000 | 94 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2019 | 4 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 18 | 0.040 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 31 | 0.040 |
Why?
|
| Lactation | 1 | 2019 | 11 | 0.040 |
Why?
|
| Mothers | 1 | 2019 | 17 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 104 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 49 | 0.040 |
Why?
|
| Cytokines | 1 | 2019 | 80 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 143 | 0.040 |
Why?
|
| Infusions, Intra-Arterial | 2 | 1996 | 2 | 0.030 |
Why?
|
| Capillaries | 1 | 1997 | 11 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 280 | 0.030 |
Why?
|
| Turner Syndrome | 1 | 1997 | 2 | 0.030 |
Why?
|
| Bone Density | 1 | 1997 | 25 | 0.030 |
Why?
|
| Radiography | 2 | 1995 | 20 | 0.030 |
Why?
|
| Ductus Arteriosus | 1 | 2016 | 1 | 0.030 |
Why?
|
| Taiwan | 1 | 2016 | 4 | 0.030 |
Why?
|
| Echocardiography | 1 | 2016 | 15 | 0.030 |
Why?
|
| Creatinine | 1 | 2016 | 48 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 1996 | 54 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1993 | 64 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 1996 | 3 | 0.030 |
Why?
|
| Liver Extracts | 1 | 1996 | 2 | 0.030 |
Why?
|
| Sleep, REM | 1 | 1996 | 5 | 0.030 |
Why?
|
| Placental Extracts | 1 | 1996 | 2 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Cell Separation | 1 | 2015 | 6 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 115 | 0.030 |
Why?
|
| Birth Weight | 1 | 1996 | 33 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2015 | 17 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 48 | 0.030 |
Why?
|
| Lipids | 1 | 2015 | 35 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2015 | 6 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 9 | 0.030 |
Why?
|
| Arteriovenous Anastomosis | 1 | 1995 | 1 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 10 | 0.030 |
Why?
|
| Fetal Death | 1 | 1995 | 6 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 1995 | 13 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1995 | 13 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 1995 | 16 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1995 | 21 | 0.030 |
Why?
|
| Airway Obstruction | 1 | 1994 | 1 | 0.030 |
Why?
|
| Nose | 1 | 1994 | 2 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 13 | 0.030 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Nanog Homeobox Protein | 1 | 2013 | 2 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2013 | 13 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2013 | 16 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1993 | 8 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 118 | 0.020 |
Why?
|
| Mutagens | 1 | 2013 | 1 | 0.020 |
Why?
|
| Nitrous Acid | 1 | 2013 | 1 | 0.020 |
Why?
|
| Comet Assay | 1 | 2013 | 1 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2013 | 2 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 8 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2012 | 5 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 6 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 43 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 102 | 0.020 |
Why?
|
| Amphotericin B | 1 | 1992 | 4 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 20 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 2011 | 2 | 0.020 |
Why?
|
| Air Pollution, Indoor | 1 | 2011 | 3 | 0.020 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2011 | 1 | 0.020 |
Why?
|
| Airway Remodeling | 1 | 2011 | 1 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 9 | 0.020 |
Why?
|
| Collagen | 1 | 2011 | 31 | 0.020 |
Why?
|
| Health Policy | 1 | 2011 | 26 | 0.020 |
Why?
|
| Cotinine | 1 | 2011 | 21 | 0.020 |
Why?
|
| Isotopes | 1 | 2008 | 1 | 0.020 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2008 | 1 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2008 | 10 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 17 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 53 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2008 | 25 | 0.020 |
Why?
|
| Defecation | 1 | 2007 | 3 | 0.020 |
Why?
|
| Gastrointestinal Motility | 1 | 2007 | 8 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2007 | 19 | 0.020 |
Why?
|
| Child, Preschool | 3 | 1997 | 258 | 0.010 |
Why?
|
| Pneumonia | 1 | 1984 | 4 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1984 | 12 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 21 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 1984 | 36 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 118 | 0.010 |
Why?
|
| Child | 3 | 1997 | 524 | 0.010 |
Why?
|
| Mucopolysaccharidosis IV | 1 | 1981 | 1 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1981 | 2 | 0.010 |
Why?
|
| Adolescent | 3 | 1997 | 869 | 0.010 |
Why?
|
| Chemoreceptor Cells | 1 | 2000 | 1 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2000 | 2 | 0.010 |
Why?
|
| Medulla Oblongata | 1 | 2000 | 3 | 0.010 |
Why?
|
| Naloxone | 1 | 2000 | 22 | 0.010 |
Why?
|
| Narcotic Antagonists | 1 | 2000 | 29 | 0.010 |
Why?
|
| Narcotics | 1 | 2000 | 16 | 0.010 |
Why?
|
| Vasodilation | 1 | 2000 | 5 | 0.010 |
Why?
|
| Swine | 1 | 2000 | 8 | 0.010 |
Why?
|
| Morphine | 1 | 2000 | 47 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2000 | 13 | 0.010 |
Why?
|
| Biological Availability | 1 | 2000 | 8 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2000 | 17 | 0.010 |
Why?
|
| Stomach | 1 | 2000 | 8 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2000 | 17 | 0.010 |
Why?
|
| Estrogens | 1 | 1997 | 27 | 0.010 |
Why?
|
| Puberty | 1 | 1997 | 17 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1997 | 140 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1996 | 16 | 0.010 |
Why?
|
| Pulmonary Ventilation | 1 | 1995 | 1 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1996 | 17 | 0.010 |
Why?
|
| Child Development | 1 | 1995 | 21 | 0.010 |
Why?
|
| Movement | 1 | 1995 | 5 | 0.010 |
Why?
|
| Social Behavior Disorders | 1 | 1974 | 1 | 0.010 |
Why?
|
| Lithium | 1 | 1974 | 4 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 1974 | 7 | 0.010 |
Why?
|
| Prevalence | 1 | 1995 | 259 | 0.010 |
Why?
|
| Myelography | 1 | 1993 | 3 | 0.010 |
Why?
|
| Electromyography | 1 | 1993 | 20 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1993 | 57 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1993 | 127 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1993 | 681 | 0.010 |
Why?
|
| Acute Disease | 1 | 1984 | 91 | 0.000 |
Why?
|
| Pneumonia, Viral | 1 | 1984 | 20 | 0.000 |
Why?
|
| Thoracic Vertebrae | 1 | 1981 | 2 | 0.000 |
Why?
|
| Lumbar Vertebrae | 1 | 1981 | 7 | 0.000 |
Why?
|
| Social Adjustment | 1 | 1974 | 2 | 0.000 |
Why?
|
| Middle Aged | 1 | 1974 | 2108 | 0.000 |
Why?
|